메뉴 건너뛰기




Volumn 144, Issue , 2014, Pages

Asking about adherence - From flipping the coin to strong evidence

Author keywords

Adherence; Antiretroviral therapy; Prevention; Self report; Surveillance

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COBICISTAT; EFAVIRENZ; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RITONAVIR; ANTIRETROVIRUS AGENT;

EID: 84919754508     PISSN: 14247860     EISSN: 14243997     Source Type: Journal    
DOI: 10.4414/smw.2014.14016     Document Type: Article
Times cited : (14)

References (93)
  • 6
    • 0041827389 scopus 로고    scopus 로고
    • High levels of adherence do not prevent accumulation of HIV drug resistance mutations
    • Bangsberg DR, Charlebois ED, Grant RM, Holodniy M, Deeks SG, Perry S, et al. High levels of adherence do not prevent accumulation of HIV drug resistance mutations. AIDS. 2003;17(13):1925-32.
    • (2003) AIDS , vol.17 , Issue.13 , pp. 1925-1932
    • Bangsberg, D.R.1    Charlebois, E.D.2    Grant, R.M.3    Holodniy, M.4    Deeks, S.G.5    Perry, S.6
  • 7
    • 55249084385 scopus 로고    scopus 로고
    • Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: Results of a randomized controlled trial
    • Burman W, Grund B, Neuhaus J, Douglas J, Jr., Friedland G, Telzak E, et al. Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial. J Acquir Immune Defic Syndr. 2008;49(2):142-50.
    • (2008) J Acquir Immune Defic Syndr , vol.49 , Issue.2 , pp. 142-150
    • Burman, W.1    Grund, B.2    Neuhaus, J.3    Douglas, J.4    Friedland, G.5    Telzak, E.6
  • 8
    • 0032562985 scopus 로고    scopus 로고
    • Public health implications of antiretroviral therapy and HIV drug resistance
    • Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA. 1998;279(24):1977-83.
    • (1998) JAMA , vol.279 , Issue.24 , pp. 1977-1983
    • Wainberg, M.A.1    Friedland, G.2
  • 10
    • 79953731323 scopus 로고    scopus 로고
    • Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings
    • Phillips AN, Pillay D, Garnett G, Bennett D, Vitoria M, Cambiano V, et al. Effect on transmission of HIV-1 resistance of timing of implementation of viral load monitoring to determine switches from first to second-line antiretroviral regimens in resource-limited settings. AIDS. 2011;25(6):843-50.
    • (2011) AIDS , vol.25 , Issue.6 , pp. 843-850
    • Phillips, A.N.1    Pillay, D.2    Garnett, G.3    Bennett, D.4    Vitoria, M.5    Cambiano, V.6
  • 11
    • 84878285851 scopus 로고    scopus 로고
    • Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings
    • Cambiano V, Bertagnolio S, Jordan MR, Lundgren JD, Phillips A. Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings. J Infect Dis. 2013;207Suppl 2:S57-62.
    • (2013) J Infect Dis , Issue.207 , pp. S57-S62
    • Cambiano, V.1    Bertagnolio, S.2    Jordan, M.R.3    Lundgren, J.D.4    Phillips, A.5
  • 12
    • 0034604276 scopus 로고    scopus 로고
    • Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
    • Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21-30.
    • (2000) Ann Intern Med , vol.133 , Issue.1 , pp. 21-30
    • Paterson, D.L.1    Swindells, S.2    Mohr, J.3    Brester, M.4    Vergis, E.N.5    Squier, C.6
  • 13
    • 34247560160 scopus 로고    scopus 로고
    • HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%
    • Shuter J, Sarlo JA, Kanmaz TJ, Rode RA, Zingman BS. HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. J Acquir Immune Defic Syndr. 2007;45(1):4-8.
    • (2007) J Acquir Immune Defic Syndr , vol.45 , Issue.1 , pp. 4-8
    • Shuter, J.1    Sarlo, J.A.2    Kanmaz, T.J.3    Rode, R.A.4    Zingman, B.S.5
  • 14
    • 11144236109 scopus 로고    scopus 로고
    • Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors
    • Maggiolo F, Ravasio L, Ripamonti D, Gregis G, Quinzan G, Arici C, et al. Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitors. Clin Infect Dis. 2005;40(1):158-63.
    • (2005) Clin Infect Dis , vol.40 , Issue.1 , pp. 158-163
    • Maggiolo, F.1    Ravasio, L.2    Ripamonti, D.3    Gregis, G.4    Quinzan, G.5    Arici, C.6
  • 15
    • 11144222165 scopus 로고    scopus 로고
    • Are nonnucleoside analogue-based regimens better than protease inhibitor-based regimens for nonadherent HIV-infected patients?
    • Knobel H. Are nonnucleoside analogue-based regimens better than protease inhibitor-based regimens for nonadherent HIV-infected patients? Clin Infect Dis. 2005;40(1):164-6.
    • (2005) Clin Infect Dis , vol.40 , Issue.1 , pp. 164-166
    • Knobel, H.1
  • 16
    • 33748646971 scopus 로고    scopus 로고
    • Adherence to antiretroviral therapy: How much is enough?
    • Gulick RM. Adherence to antiretroviral therapy: how much is enough? Clin Infect Dis. 2006;43(7):942-4.
    • (2006) Clin Infect Dis , vol.43 , Issue.7 , pp. 942-944
    • Gulick, R.M.1
  • 17
    • 85027920347 scopus 로고    scopus 로고
    • Patterns of adherence to raltegravir-based regimens and the risk of virological failure among HIV-infected patients: The RALTECAPS cohort study
    • Gras G, Schneider MP, Cavassini M, Lucht F, Loilier M, Verdon R, et al. Patterns of adherence to raltegravir-based regimens and the risk of virological failure among HIV-infected patients: the RALTECAPS cohort study. Journal of acquired immune deficiency syndromes. 2012;61(3):265-9.
    • (2012) Journal of Acquired Immune Deficiency Syndromes , vol.61 , Issue.3 , pp. 265-269
    • Gras, G.1    Schneider, M.P.2    Cavassini, M.3    Lucht, F.4    Loilier, M.5    Verdon, R.6
  • 18
    • 41149122707 scopus 로고    scopus 로고
    • Forgiveness of non-adherence to HIV-1 antiretroviral therapy
    • Shuter J. Forgiveness of non-adherence to HIV-1 antiretroviral therapy. J Antimicrob Chemother. 2008;61(4):769-73.
    • (2008) J Antimicrob Chemother , vol.61 , Issue.4 , pp. 769-773
    • Shuter, J.1
  • 19
    • 33748642352 scopus 로고    scopus 로고
    • Less than 95% adherence to nonnucleoside reversetranscriptase inhibitor therapy can lead to viral suppression
    • Bangsberg DR. Less than 95% adherence to nonnucleoside reversetranscriptase inhibitor therapy can lead to viral suppression. Clin Infect Dis. 2006;43(7):939-41.
    • (2006) Clin Infect Dis , vol.43 , Issue.7 , pp. 939-941
    • Bangsberg, D.R.1
  • 20
    • 34247583029 scopus 로고    scopus 로고
    • Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes
    • Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med. 2007;146(8):564-73.
    • (2007) Ann Intern Med , vol.146 , Issue.8 , pp. 564-573
    • Nachega, J.B.1    Hislop, M.2    Dowdy, D.W.3    Chaisson, R.E.4    Regensberg, L.5    Maartens, G.6
  • 21
    • 33645102908 scopus 로고    scopus 로고
    • Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors
    • Liu H, Miller LG, Hays RD, Golin CE, Wu T, Wenger NS, et al. Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. J Acquir Immune Defic Syndr. 2006;41(3):315-22.
    • (2006) J Acquir Immune Defic Syndr , vol.41 , Issue.3 , pp. 315-322
    • Liu, H.1    Miller, L.G.2    Hays, R.D.3    Golin, C.E.4    Wu, T.5    Wenger, N.S.6
  • 22
    • 70349645396 scopus 로고    scopus 로고
    • The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy
    • Rosenblum M, Deeks SG, van der LM, Bangsberg DR. The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy. PLoS One. 2009;4(9):e7196.
    • (2009) PLoS One , vol.4 , Issue.9
    • Rosenblum, M.1    Deeks, S.G.2    Van Der, L.M.3    Bangsberg, D.R.4
  • 23
    • 84885767147 scopus 로고    scopus 로고
    • Adherence as a predictor of the development of class-specific resistance mutations: The Swiss HIV Cohort Study
    • von Wyl V, Klimkait T, Yerly S, Nicca D, Furrer H, Cavassini M, et al. Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study. PloS One. 2013;8(10):e77691.
    • (2013) PloS One , vol.8 , Issue.10
    • Von Wyl, V.1    Klimkait, T.2    Yerly, S.3    Nicca, D.4    Furrer, H.5    Cavassini, M.6
  • 24
    • 25044456551 scopus 로고
    • TB threat: Not taking the medicine. Partly cured patients are the deadliest carriers
    • Belkin L. TB threat: not taking the medicine. Partly cured patients are the deadliest carriers. New York Times. 1991 1991.
    • (1991) New York Times
    • Belkin, L.1
  • 26
    • 2442689168 scopus 로고    scopus 로고
    • Paradoxes of adherence and drug resistance to HIV antiretroviral therapy
    • Bangsberg DR, Moss AR, Deeks SG. Paradoxes of adherence and drug resistance to HIV antiretroviral therapy. J Antimicrob Chemother. 2004;53(5):696-9.
    • (2004) J Antimicrob Chemother , vol.53 , Issue.5 , pp. 696-699
    • Bangsberg, D.R.1    Moss, A.R.2    Deeks, S.G.3
  • 27
    • 36048981531 scopus 로고    scopus 로고
    • Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in N
    • Maggiolo F, Airoldi M, Kleinloog HD, Callegaro A, Ravasio V, Arici C, et al. Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in N. HIV Clin Trials. 2007;8(5):282-92.
    • (2007) HIV Clin Trials , vol.8 , Issue.5 , pp. 282-292
    • Maggiolo, F.1    Airoldi, M.2    Kleinloog, H.D.3    Callegaro, A.4    Ravasio, V.5    Arici, C.6
  • 28
    • 58149146880 scopus 로고    scopus 로고
    • The relationship between resistance and adherence in drugnaive individuals initiating HAART is specific to individual drug classes
    • Tam LW, Chui CK, Brumme CJ, Bangsberg DR, Montaner JS, Hogg RS, et al. The relationship between resistance and adherence in drugnaive individuals initiating HAART is specific to individual drug classes. J AcquirImmune Defic Syndr. 2008;49(3):266-71.
    • (2008) J AcquirImmune Defic Syndr , vol.49 , Issue.3 , pp. 266-271
    • Tam, L.W.1    Chui, C.K.2    Brumme, C.J.3    Bangsberg, D.R.4    Montaner, J.S.5    Hogg, R.S.6
  • 29
    • 34548655652 scopus 로고    scopus 로고
    • Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: A comparison of different regimen types
    • von W, V, Yerly S, Boni J, Burgisser P, Klimkait T, Battegay M, et al. Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Arch Intern Med. 2007;167(16):1782-90.
    • (2007) Arch Intern Med , vol.167 , Issue.16 , pp. 1782-1790
    • Von, W.V.1    Yerly, S.2    Boni, J.3    Burgisser, P.4    Klimkait, T.5    Battegay, M.6
  • 30
    • 33646034630 scopus 로고    scopus 로고
    • Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness
    • Bangsberg DR, Acosta EP, Gupta R, Guzman D, Riley ED, Harrigan PR, et al. Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness. AIDS. 2006;20(2):223-31.
    • (2006) AIDS , vol.20 , Issue.2 , pp. 223-231
    • Bangsberg, D.R.1    Acosta, E.P.2    Gupta, R.3    Guzman, D.4    Riley, E.D.5    Harrigan, P.R.6
  • 31
    • 20444430423 scopus 로고    scopus 로고
    • Relationship between adherence and the development of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or nelfinavir
    • King MS, Brun SC, Kempf DJ. Relationship between adherence and the development of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or nelfinavir. J Infect Dis. 2005;191(12):2046-52.
    • (2005) J Infect Dis , vol.191 , Issue.12 , pp. 2046-2052
    • King, M.S.1    Brun, S.C.2    Kempf, D.J.3
  • 33
    • 2342589337 scopus 로고    scopus 로고
    • Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy
    • Parienti JJ, Massari V, Descamps D, Vabret A, Bouvet E, Larouze B, et al. Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. Clin Infect Dis. 2004;38(9):1311-6.
    • (2004) Clin Infect Dis , vol.38 , Issue.9 , pp. 1311-1316
    • Parienti, J.J.1    Massari, V.2    Descamps, D.3    Vabret, A.4    Bouvet, E.5    Larouze, B.6
  • 34
    • 0142218458 scopus 로고    scopus 로고
    • Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance
    • Sethi AK, Celentano DD, Gange SJ, Moore RD, Gallant JE. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis. 2003;37(8):1112-8.
    • (2003) Clin Infect Dis , vol.37 , Issue.8 , pp. 1112-1118
    • Sethi, A.K.1    Celentano, D.D.2    Gange, S.J.3    Moore, R.D.4    Gallant, J.E.5
  • 35
    • 0033816265 scopus 로고    scopus 로고
    • Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission
    • Jackson JB, Becker-Pergola G, Guay LA, Musoke P, Mracna M, Fowler MG, et al. Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. AIDS. 2000;14(11):F111-F5.
    • (2000) AIDS , vol.14 , Issue.11 , pp. F111-F115
    • Jackson, J.B.1    Becker-Pergola, G.2    Guay, L.A.3    Musoke, P.4    Mracna, M.5    Fowler, M.G.6
  • 36
    • 34047198735 scopus 로고    scopus 로고
    • Pilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-week results of the five-days-on, two-days-off (FOTO) study
    • Cohen CJ, Colson AE, Sheble-Hall AG, McLaughlin KA, Morse GD. Pilot study of a novel short-cycle antiretroviral treatment interruption strategy: 48-week results of the five-days-on, two-days-off (FOTO) study. HIV clinical trials. 2007;8(1):19-23.
    • (2007) HIV Clinical Trials , vol.8 , Issue.1 , pp. 19-23
    • Cohen, C.J.1    Colson, A.E.2    Sheble-Hall, A.G.3    McLaughlin, K.A.4    Morse, G.D.5
  • 37
    • 47549090814 scopus 로고    scopus 로고
    • Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy
    • Hare CB, Mellors J, Krambrink A, Su Z, Skiest D, Margolis DM, et al. Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy. Clin Infect Dis. 2008;47(3):421-4.
    • (2008) Clin Infect Dis , vol.47 , Issue.3 , pp. 421-424
    • Hare, C.B.1    Mellors, J.2    Krambrink, A.3    Su, Z.4    Skiest, D.5    Margolis, D.M.6
  • 38
    • 84870015697 scopus 로고    scopus 로고
    • Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens
    • Scherrer AU, Boni J, Yerly S, Klimkait T, Aubert V, Furrer H, et al. Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens. PloS One. 2012;7(11):e50307.
    • (2012) PloS One , vol.7 , Issue.11
    • Scherrer, A.U.1    Boni, J.2    Yerly, S.3    Klimkait, T.4    Aubert, V.5    Furrer, H.6
  • 39
    • 36148932954 scopus 로고    scopus 로고
    • The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: Implications in clinical practice
    • Villes V, Spire B, Lewden C, Perronne C, Besnier JM, Garre M, et al. The effect of depressive symptoms at ART initiation on HIV clinical progression and mortality: implications in clinical practice. Antivir Ther. 2007;12(7):1067-74.
    • (2007) Antivir Ther , vol.12 , Issue.7 , pp. 1067-1074
    • Villes, V.1    Spire, B.2    Lewden, C.3    Perronne, C.4    Besnier, J.M.5    Garre, M.6
  • 40
    • 0037013038 scopus 로고    scopus 로고
    • Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up
    • Hogg RS, Heath K, Bangsberg D, Yip B, Press N, O'Shaughnessy MV, et al. Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up. AIDS. 2002;16(7):1051-8.
    • (2002) AIDS , vol.16 , Issue.7 , pp. 1051-1058
    • Hogg, R.S.1    Heath, K.2    Bangsberg, D.3    Yip, B.4    Press, N.5    O'Shaughnessy, M.V.6
  • 42
    • 65449153627 scopus 로고    scopus 로고
    • The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time
    • Lima VD, Harrigan R, Bangsberg DR, Hogg RS, Gross R, Yip B, et al. The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time. J Acquir Immune Defic Syndr. 2009;50(5):529-36.
    • (2009) J Acquir Immune Defic Syndr , vol.50 , Issue.5 , pp. 529-536
    • Lima, V.D.1    Harrigan, R.2    Bangsberg, D.R.3    Hogg, R.S.4    Gross, R.5    Yip, B.6
  • 43
    • 0035876041 scopus 로고    scopus 로고
    • Non-adherence to highly active antiretroviral therapy predicts progression to AIDS
    • Bangsberg DR, Perry S, Charlebois ED, Clark RA, Roberston M, Zolopa AR, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181-3.
    • (2001) AIDS , vol.15 , Issue.9 , pp. 1181-1183
    • Bangsberg, D.R.1    Perry, S.2    Charlebois, E.D.3    Clark, R.A.4    Roberston, M.5    Zolopa, A.R.6
  • 44
    • 33745928735 scopus 로고    scopus 로고
    • A meta-analysis of the association between adherence to drug therapy and mortality
    • Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.
    • (2006) BMJ , vol.333 , Issue.7557 , pp. 15
    • Simpson, S.H.1    Eurich, D.T.2    Majumdar, S.R.3    Padwal, R.S.4    Tsuyuki, R.T.5    Varney, J.6
  • 45
    • 33845213582 scopus 로고    scopus 로고
    • HIV in semen: Still more to be learned
    • Vernazza PL. HIV in semen: still more to be learned. AIDS ResTher. 2005;2:11.
    • (2005) AIDS ResTher , vol.2 , pp. 11
    • Vernazza, P.L.1
  • 46
    • 3142733645 scopus 로고    scopus 로고
    • Antiretroviral therapy to reduce the sexual transmission of HIV
    • Taylor S, Boffito M, Vernazza PL. Antiretroviral therapy to reduce the sexual transmission of HIV. JHIV Ther. 2003;8(3):55-66.
    • (2003) JHIV Ther , vol.8 , Issue.3 , pp. 55-66
    • Taylor, S.1    Boffito, M.2    Vernazza, P.L.3
  • 48
    • 77953293984 scopus 로고    scopus 로고
    • Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis
    • Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375(9731):2092-8.
    • (2010) Lancet , vol.375 , Issue.9731 , pp. 2092-2098
    • Donnell, D.1    Baeten, J.M.2    Kiarie, J.3    Thomas, K.K.4    Stevens, W.5    Cohen, C.R.6
  • 49
    • 78349233841 scopus 로고    scopus 로고
    • Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: The strategic use of antiretroviral drugs to prevent HIV acquisition and transmission
    • Weber J, Tatoud R, Fidler S. Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: the strategic use of antiretroviral drugs to prevent HIV acquisition and transmission. AIDS. 2010;24Suppl4:S27-39.
    • (2010) AIDS , Issue.24 , pp. S27-S39
    • Weber, J.1    Tatoud, R.2    Fidler, S.3
  • 51
    • 84864507088 scopus 로고    scopus 로고
    • Preexposure prophylaxis for HIV - Where do we go from here?
    • Cohen MS, Baden LR. Preexposure prophylaxis for HIV - where do we go from here? N Engl J Med. 2012;367(5):459-61.
    • (2012) N Engl J Med , vol.367 , Issue.5 , pp. 459-461
    • Cohen, M.S.1    Baden, L.R.2
  • 53
    • 84864505868 scopus 로고    scopus 로고
    • Antiretroviral prophylaxis for HIV prevention in heterosexual men and women
    • Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399-410.
    • (2012) N Engl J Med , vol.367 , Issue.5 , pp. 399-410
    • Baeten, J.M.1    Donnell, D.2    Ndase, P.3    Mugo, N.R.4    Campbell, J.D.5    Wangisi, J.6
  • 56
    • 81855218587 scopus 로고    scopus 로고
    • HIV testing and antiretroviral treatment strategies for prevention of HIV infection: Impact on antiretroviral drug resistance
    • Nichols BE, Boucher CA, van de Vijver DA. HIV testing and antiretroviral treatment strategies for prevention of HIV infection: impact on antiretroviral drug resistance. J Intern Med. 2011;270(6):532-49.
    • (2011) J Intern Med , vol.270 , Issue.6 , pp. 532-549
    • Nichols, B.E.1    Boucher, C.A.2    Van De Vijver, D.A.3
  • 58
    • 77953040583 scopus 로고    scopus 로고
    • Longitudinal analysis of patterns and predictors of changes in selfreported adherence to antiretroviral therapy: Swiss HIV Cohort Study
    • Glass TR, Battegay M, Cavassini M, De GS, Furrer H, Vernazza PL, et al. Longitudinal analysis of patterns and predictors of changes in selfreported adherence to antiretroviral therapy: Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2010;54(2):197-203.
    • (2010) J Acquir Immune Defic Syndr , vol.54 , Issue.2 , pp. 197-203
    • Glass, T.R.1    Battegay, M.2    Cavassini, M.3    De, G.S.4    Furrer, H.5    Vernazza, P.L.6
  • 59
    • 67449146275 scopus 로고    scopus 로고
    • Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term followup
    • Knobel H, Urbina O, Gonzalez A, Sorli ML, Montero M, Carmona A, et al. Impact of different patterns of nonadherence on the outcome of highly active antiretroviral therapy in patients with long-term followup. HIV Med. 2009;10(6):364-9.
    • (2009) HIV Med , vol.10 , Issue.6 , pp. 364-369
    • Knobel, H.1    Urbina, O.2    Gonzalez, A.3    Sorli, M.L.4    Montero, M.5    Carmona, A.6
  • 60
    • 36048955893 scopus 로고    scopus 로고
    • Patterns and predictors of changes in adherence to highly active antiretroviral therapy: Longitudinal study of men and women
    • Lazo M, Gange SJ, Wilson TE, Anastos K, Ostrow DG, Witt MD, et al. Patterns and predictors of changes in adherence to highly active antiretroviral therapy: longitudinal study of men and women. ClinInfectDis. 2007;45(10):1377-85.
    • (2007) ClinInfectDis , vol.45 , Issue.10 , pp. 1377-1385
    • Lazo, M.1    Gange, S.J.2    Wilson, T.E.3    Anastos, K.4    Ostrow, D.G.5    Witt, M.D.6
  • 61
    • 27744600622 scopus 로고    scopus 로고
    • Variations in patterns of highly active antiretroviral therapy (HAART) adherence
    • Levine AJ, Hinkin CH, Castellon SA, Mason KI, Lam MN, Perkins A, et al. Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS Behav. 2005;9(3):355-62.
    • (2005) AIDS Behav , vol.9 , Issue.3 , pp. 355-362
    • Levine, A.J.1    Hinkin, C.H.2    Castellon, S.A.3    Mason, K.I.4    Lam, M.N.5    Perkins, A.6
  • 62
    • 1642396945 scopus 로고    scopus 로고
    • Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study
    • Kleeberger CA, Buechner J, Palella F, Detels R, Riddler S, Godfrey R, et al. Changes in adherence to highly active antiretroviral therapy medications in the Multicenter AIDS Cohort Study. AIDS. 2004;18(4):683-8.
    • (2004) AIDS , vol.18 , Issue.4 , pp. 683-688
    • Kleeberger, C.A.1    Buechner, J.2    Palella, F.3    Detels, R.4    Riddler, S.5    Godfrey, R.6
  • 63
    • 0037090271 scopus 로고    scopus 로고
    • The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials
    • Mannheimer S, Friedland G, Matts J, Child C, Chesney M. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clin Infect Dis. 2002;34(8):1115-21.
    • (2002) Clin Infect Dis , vol.34 , Issue.8 , pp. 1115-1121
    • Mannheimer, S.1    Friedland, G.2    Matts, J.3    Child, C.4    Chesney, M.5
  • 64
    • 33845359660 scopus 로고    scopus 로고
    • The elusive gold standard. Future perspectives for HIV adherence assessment and intervention
    • Chesney MA. The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr. 2006;43 Suppl 1:S149-S55.
    • (2006) J Acquir Immune Defic Syndr , vol.43 , pp. S149-S155
    • Chesney, M.A.1
  • 65
    • 33845371782 scopus 로고    scopus 로고
    • Practical and conceptual challenges in measuring antiretroviral adherence
    • Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43 Suppl 1:S79-87.
    • (2006) J Acquir Immune Defic Syndr , vol.43 , pp. S79-S87
    • Berg, K.M.1    Arnsten, J.H.2
  • 66
    • 84872685973 scopus 로고    scopus 로고
    • A proposal for quality standards for measuring medication adherence in research
    • Williams AB, Amico KR, Bova C, Womack JA. A proposal for quality standards for measuring medication adherence in research. AIDS and behavior. 2013;17(1):284-97.
    • (2013) AIDS and Behavior , vol.17 , Issue.1 , pp. 284-297
    • Williams, A.B.1    Amico, K.R.2    Bova, C.3    Womack, J.A.4
  • 68
    • 0035873622 scopus 로고    scopus 로고
    • A comparison study of multiple measures of adherence to HIV protease inhibitors
    • Liu H, Golin CE, Miller LG, Hays RD, Beck CK, Sanandaji S, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134(10):968-77.
    • (2001) Ann Intern Med , vol.134 , Issue.10 , pp. 968-977
    • Liu, H.1    Golin, C.E.2    Miller, L.G.3    Hays, R.D.4    Beck, C.K.5    Sanandaji, S.6
  • 69
    • 84880631437 scopus 로고    scopus 로고
    • How well does self-reported adherence fare compared to therapeutic drug monitoring in HAART?
    • Bulgiba A, Mohammed UY, Chik Z, Lee C, Peramalah D. How well does self-reported adherence fare compared to therapeutic drug monitoring in HAART? Preventive medicine. 2013;57 Suppl:S34-6.
    • (2013) Preventive Medicine , vol.57 , pp. S34-S36
    • Bulgiba, A.1    Mohammed, U.Y.2    Chik, Z.3    Lee, C.4    Peramalah, D.5
  • 70
    • 0037386178 scopus 로고    scopus 로고
    • Factors associated with accurate self-reported adherence to HIV antiretrovirals
    • Kimmerling M, Wagner G, Ghosh-Dastidar B. Factors associated with accurate self-reported adherence to HIV antiretrovirals. Int JSTD AIDS. 2003;14(4):281-4.
    • (2003) Int JSTD AIDS , vol.14 , Issue.4 , pp. 281-284
    • Kimmerling, M.1    Wagner, G.2    Ghosh-Dastidar, B.3
  • 71
    • 0033865562 scopus 로고    scopus 로고
    • Measuring medication adherence: Are missed doses reported more accurately then perfect adherence?
    • Wagner GJ, Rabkin JG. Measuring medication adherence: are missed doses reported more accurately then perfect adherence? AIDS Care. 2000;12(4):405-8.
    • (2000) AIDS Care , vol.12 , Issue.4 , pp. 405-408
    • Wagner, G.J.1    Rabkin, J.G.2
  • 72
    • 33847249897 scopus 로고    scopus 로고
    • Assessing antiretroviral adherence via electronic drug monitoring and self-report: An examination of key methodological issues
    • Pearson CR, Simoni JM, Hoff P, Kurth AE, Martin DP. Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues. AIDS Behav. 2007;11(2):161-73.
    • (2007) AIDS Behav , vol.11 , Issue.2 , pp. 161-173
    • Pearson, C.R.1    Simoni, J.M.2    Hoff, P.3    Kurth, A.E.4    Martin, D.P.5
  • 73
    • 1642458239 scopus 로고    scopus 로고
    • Is the influence of social desirability on patients' self-reported adherence overrated?
    • Wagner G, Miller LG. Is the influence of social desirability on patients' self-reported adherence overrated? J Acquir Immune Defic Syndr. 2004;35(2):203-4.
    • (2004) J Acquir Immune Defic Syndr , vol.35 , Issue.2 , pp. 203-204
    • Wagner, G.1    Miller, L.G.2
  • 74
    • 70350022792 scopus 로고    scopus 로고
    • Inaccuracies in self-reported medication adherence: Findings and psychological processes
    • Dunbar-Jacob JE J, Schlenk E, Stilley C, editor., Pittsburgh, PA: University of Pittsburgh Press
    • Belli RF. Inaccuracies in self-reported medication adherence: findings and psychological processes. In: Dunbar-Jacob JE J, Schlenk E, Stilley C, editor. Methodological Issues in the Study of Adherence. Pittsburgh, PA: University of Pittsburgh Press. 2005;p.35-45.
    • (2005) Methodological Issues in the Study of Adherence , pp. 35-45
    • Belli, R.F.1
  • 75
    • 70350028747 scopus 로고    scopus 로고
    • Improving the self-report of HIV antiretroviral medication adherence: Is the glass half full or half empty?
    • Wilson IB, Carter AE, Berg KM. Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty? Curr HIV/AIDS Rep. 2009;6(4):177-86.
    • (2009) Curr HIV/AIDS Rep , vol.6 , Issue.4 , pp. 177-186
    • Wilson, I.B.1    Carter, A.E.2    Berg, K.M.3
  • 76
    • 33745277561 scopus 로고    scopus 로고
    • Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management
    • Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227-45.
    • (2006) AIDS Behav , vol.10 , Issue.3 , pp. 227-245
    • Simoni, J.M.1    Kurth, A.E.2    Pearson, C.R.3    Pantalone, D.W.4    Merrill, J.O.5    Frick, P.A.6
  • 77
    • 15044352285 scopus 로고    scopus 로고
    • Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: A meta-analysis
    • Nieuwkerk PT, Oort FJ. Self-reported adherence to antiretroviral therapy for HIV-1 infection and virologic treatment response: a meta-analysis. J Acquir Immune Defic Syndr. 2005;38(4):445-8.
    • (2005) J Acquir Immune Defic Syndr , vol.38 , Issue.4 , pp. 445-448
    • Nieuwkerk, P.T.1    Oort, F.J.2
  • 78
    • 51849149537 scopus 로고    scopus 로고
    • Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards
    • Deschamps AE, De GS, Vandamme AM, Bobbaers H, Peetermans WE, Van WE. Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. AIDS Patient Care STDS. 2008;22(9):735-43.
    • (2008) AIDS Patient Care STDS , vol.22 , Issue.9 , pp. 735-743
    • Deschamps, A.E.1    De, G.S.2    Vandamme, A.M.3    Bobbaers, H.4    Peetermans, W.E.5    Van, W.E.6
  • 79
    • 0037169259 scopus 로고    scopus 로고
    • Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome
    • Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16(2):269-77.
    • (2002) AIDS , vol.16 , Issue.2 , pp. 269-277
    • Walsh, J.C.1    Mandalia, S.2    Gazzard, B.G.3
  • 80
    • 43249083005 scopus 로고    scopus 로고
    • A randomized comparison of two instruments for measuring self-reported antiretroviral adherence
    • Mannheimer S, Thackeray L, Huppler Hullsiek K, Chesney M, Gardner EM, Wu AW, et al. A randomized comparison of two instruments for measuring self-reported antiretroviral adherence. AIDS Care. 2008;20(2):161-9.
    • (2008) AIDS Care , vol.20 , Issue.2 , pp. 161-169
    • Mannheimer, S.1    Thackeray, L.2    Huppler Hullsiek, K.3    Chesney, M.4    Gardner, E.M.5    Wu, A.W.6
  • 81
    • 33645103497 scopus 로고    scopus 로고
    • Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: The Swiss HIV Cohort Study
    • Glass TR, De Geest S, Weber R, Vernazza PL, Rickenbach M, Furrer H, et al. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr. 2006;41(3):385-92.
    • (2006) J Acquir Immune Defic Syndr , vol.41 , Issue.3 , pp. 385-392
    • Glass, T.R.1    De Geest, S.2    Weber, R.3    Vernazza, P.L.4    Rickenbach, M.5    Furrer, H.6
  • 82
    • 42149169944 scopus 로고    scopus 로고
    • Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients
    • Glass TR, De GS, Hirschel B, Battegay M, Furrer H, Covassini M, et al. Self-reported non-adherence to antiretroviral therapy repeatedly assessed by two questions predicts treatment failure in virologically suppressed patients. Antivir Ther. 2008;13(1):77-85.
    • (2008) Antivir Ther , vol.13 , Issue.1 , pp. 77-85
    • Glass, T.R.1    De, G.S.2    Hirschel, B.3    Battegay, M.4    Furrer, H.5    Covassini, M.6
  • 83
    • 2542565696 scopus 로고    scopus 로고
    • Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale
    • Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV clinical trials. 2004;5(2):74-9.
    • (2004) HIV Clinical Trials , vol.5 , Issue.2 , pp. 74-79
    • Giordano, T.P.1    Guzman, D.2    Clark, R.3    Charlebois, E.D.4    Bangsberg, D.R.5
  • 85
    • 0001696152 scopus 로고    scopus 로고
    • Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments
    • Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG)
    • Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000;12(3):255-66.
    • (2000) AIDS Care , vol.12 , Issue.3 , pp. 255-266
    • Chesney, M.A.1    Ickovics, J.R.2    Chambers, D.B.3    Gifford, A.L.4    Neidig, J.5    Zwickl, B.6
  • 86
    • 38449122616 scopus 로고    scopus 로고
    • Optimal recall period and response task for self-reported HIV medication adherence
    • Lu M, Safren SA, Skolnik PR, Rogers WH, Coady W, Hardy H, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008;12(1):86-94.
    • (2008) AIDS Behav , vol.12 , Issue.1 , pp. 86-94
    • Lu, M.1    Safren, S.A.2    Skolnik, P.R.3    Rogers, W.H.4    Coady, W.5    Hardy, H.6
  • 87
    • 9244260172 scopus 로고    scopus 로고
    • Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection
    • Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen intern Med. 2004;19(11):1096-103.
    • (2004) J Gen Intern Med , vol.19 , Issue.11 , pp. 1096-1103
    • Schneider, J.1    Kaplan, S.H.2    Greenfield, S.3    Li, W.4    Wilson, I.B.5
  • 88
    • 79956051581 scopus 로고    scopus 로고
    • An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring
    • Krummenacher I, Cavassini M, Bugnon O, Schneider MP. An interdisciplinary HIV-adherence program combining motivational interviewing and electronic antiretroviral drug monitoring. AIDS Care. 2011;23(5):550-61.
    • (2011) AIDS Care , vol.23 , Issue.5 , pp. 550-561
    • Krummenacher, I.1    Cavassini, M.2    Bugnon, O.3    Schneider, M.P.4
  • 91
    • 44449123557 scopus 로고    scopus 로고
    • Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy
    • Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, Regensberg L, et al. Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy. PLoS medicine. 2008;5(5):e109.
    • (2008) PLoS Medicine , vol.5 , Issue.5 , pp. e109
    • Bisson, G.P.1    Gross, R.2    Bellamy, S.3    Chittams, J.4    Hislop, M.5    Regensberg, L.6
  • 92
    • 0037114856 scopus 로고    scopus 로고
    • Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature
    • Ammassari A, Trotta MP, Murri R, Castelli F, Narciso P, Noto P, et al. Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr. 2002;31 Suppl 3:S123-S7.
    • (2002) J Acquir Immune Defic Syndr , vol.31 , pp. S123-S127
    • Ammassari, A.1    Trotta, M.P.2    Murri, R.3    Castelli, F.4    Narciso, P.5    Noto, P.6
  • 93
    • 33645108959 scopus 로고    scopus 로고
    • Efficacy of antiretroviral therapy adherence interventions: A research synthesis of trials, 1996 to 2004
    • Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41(3):285-97.
    • (2006) J Acquir Immune Defic Syndr , vol.41 , Issue.3 , pp. 285-297
    • Amico, K.R.1    Harman, J.J.2    Johnson, B.T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.